Acceptance rate:
Time to first decision with review (median):
25 days*
Acceptance to publication:
18 days*
Impact Factor (JCR):
Citescore rank:

Aims and scope

Journal of Clinical Pathology (JCP) offers a mix of innovative academic research and practical clinical advice. As one of the few broad-scope pathology journals, it enables the busy pathologist to keep up with the latest developments in all pathology disciplines. In addition to original research, JCP publishes a wide range of other content types aimed at the training and practising pathologist, such as computational pathology, review articles on hot topics, best practice articles for clinical investigations, in-depth summaries of key genes and molecules in pathogenesis, and multi-disciplinary grand rounds cases. The journal does not typically publish papers that focus on basic research, although translational pathology articles are welcomed. Exceptional case reports that contribute significantly to our understanding of the pathogenesis or diagnosis of disease may be published. Selected articles have accredited online learning modules for self-assessment and CME. JCP is the official journal of the Association of Clinical Pathologists. Molecular Pathology was merged with JCP in 2003. For information about the Journal of Clinical Pathology Editor-in-Chief Vikram Deshpande and his editorial team, please refer to the Editorial Board page.

Plan S compliance

Journal of Clinical Pathology is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and  Plan S compliance on our Author Hub.

Journal information

JCP is owned by the Association of Clinical Pathologists and BMJ
Publication Model
Subscription; with hybrid open access option
Launch date
1947; Molecular Pathology merged with JCP in 2003
Digital Archives
Indexed by
Web of Science Core Collection: Science Citation Index, Science Citation Index Expanded; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences; MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
Online ISSN

Journal Statistics 2024

Acceptance rate: 27%
Speed Time to first decision without review: 1 day (median) Time to first decision with review: 25 days (median) Time from acceptance to publication: 18 days (median)
Impact Impact Factor category: Pathology Impact Factor (JCR): 2.5 Impact Factor rank: 37/88 5 Year Impact Factor: 2.8 Journal Citation Indicator (JCI): 1.09 Eigenfactor Score: 0.0053 Citescore: 7.8 Citescore rank: 22/208 SciMago Journal Rank (SJR): 0.934
Reach Total content views: 522,100 Total Altmetric mentions: 2,967
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure. How we get these metrics

Contact information

For all contact information please refer to the contact us page.

For authors

Please refer to the Instructions for authors


COPE logo
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. BMJ is a sponsor of its activities.
AllTrials logo
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.